Home > Compound List > Product Information
2-(Trifluoromethoxy)phenylboronic acid_Molecular_structure_CAS_175676-65-0)
Click picture or here to close

2-(Trifluoromethoxy)phenylboronic acid

Catalog No. 683787 Name Sigma Aldrich
CAS Number 175676-65-0 Website http://www.sigmaaldrich.com
M. F. C7H6BF3O3 Telephone 1-800-521-8956
M. W. 205.9269496 Fax
Purity Email
Storage Chembase ID: 9183

SYNONYMS

Title
2-(三氟甲氧基)苯硼酸
IUPAC name
[2-(trifluoromethoxy)phenyl]boronic acid
IUPAC Traditional name
2-(trifluoromethoxy)phenylboronic acid
Synonyms
2-(Trifluoromethoxy)benzeneboronic acid

DATABASE IDS

CAS Number 175676-65-0
PubChem SID 24885779
MDL Number MFCD01320763

PROPERTIES

Linear Formula F3CO(C6H4)B(OH)2
MSDS Link Download
German water hazard class 3

DETAILS

Description (English)
General description
May contain varying amounts of anhydride.
Packaging
1, 5 g in glass bottle
Application
Reactant for:
• Preparation of imidazo[1,5-a]pyrido[3,2-e]pyrazines and imidazo[1,5-a]quinoxalines as orally active phosphodiesterase 10A inhibitors1
• Suzuki-Miyaura cross-coupling reactions2
• Preparation of 3-(5-arylbenzimidazol-2-yl)-1-oxa-2-azaspiro[4.5]decenes as transient receptor potential melastatin 8 antagonists3
• Preparation of biaryl pyrazole carboxamides as sodium channel blockers for treatment of neuropathic pain4
• Preparation of biaryl oxazoles, imidazoles and thiazoles via condensations as sodium channel blockers and CYP inhibitors for treatment of neuropathic pain5
Description (简体中文)
General description
可能含有不定量的酸酐。
包装
1, 5 g in glass bottle
Application
Reactant for:
• Preparation of imidazo[1,5-a]pyrido[3,2-e]pyrazines and imidazo[1,5-a]quinoxalines as orally active phosphodiesterase 10A inhibitors1
• Suzuki-Miyaura cross-coupling reactions2
• Preparation of 3-(5-arylbenzimidazol-2-yl)-1-oxa-2-azaspiro[4.5]decenes as transient receptor potential melastatin 8 antagonists3
• Preparation of biaryl pyrazole carboxamides as sodium channel blockers for treatment of neuropathic pain4
• Preparation of biaryl oxazoles, imidazoles and thiazoles via condensations as sodium channel blockers and CYP inhibitors for treatment of neuropathic pain5

REFERENCES